European committee takes a second look at Alzheimer's drug and now says it should be approved
A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting the drug.
Health on MSN39m
Millions of Americans Likely Have Sleep Apnea—Could It Raise the Risk of Dementia?
Obstructive sleep apnea has been linked to an increased risk of dementia in a new study—and the association was particularly ...
InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
The Company's full financial statements and related MD&A for the first quarter ended September 30, 2024, are available at www.inmedpharma.com, www.sedar.com and at www.sec.gov.